FindTrial
Sign In

Study on the Ability of Virtual Reality Glasses in Anxiety and Pain Reduction in 50 Women Undergoing Amniocentesis or Feticide

The Ability of Virtual Reality in Anxiety and Pain Reduction in Women Undergoing Amniocentesis or Feticide

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04491149
Enrollment
100
Registered
2020-07-29
Start date
2020-09-01
Completion date
2021-03-31
Last updated
2020-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amniocentesis, Anxiety Acute, Foeticide

Brief summary

Both amniocenteses and especially feticide are procedures that incorporate both anxiety and pain. As anxiety and pain can be reduced when using a distraction, The investigators speculate that the use of virtual reality glasses during these procedures will elevate both anxiety and pain. The investigators will examine this hypothesis by comparing two groups of participants who undergo amniocentesis or feticide, one group will undergo the procedure while using virtual reality glasses and the other without the use of the glasses.

Interventions

DEVICEvirtual reality glasses

In the intervention arm, women undergoing amniocentesis/foeticide will use virtual reality glasses during the procedure.

Sponsors

Assaf-Harofeh Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

Pregnant women undergoing amniocentesis/foeticide who will sign an informed consent form \-

Exclusion criteria

* Women younger than 18 years * Twin pregnancies * Women with vertigo

Design outcomes

Primary

MeasureTime frameDescription
Anxiety levelUp to one hour before the procedureSpielberger's State-Trait Anxiety Inventory

Countries

Israel

Contacts

Primary ContactRan Svirsky, MD
rsvirs@gmail.com972-89779000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026